Synergy Hematology Oncology Medical Associates INC
Synergy Hematology Oncology Medical Associates INC was paid $1.01M by Medicaid between Jan 2018 and Nov 2024, across 70 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 19% of everything it billed.
33Billing provider infoSYNERGY HEMATOLOGY ONCOLOGY MEDICAL ASSOCIATES INC
WEST HOLLYWOOD, CA 90048
WEST HOLLYWOOD, CA 90048
33aNPI1164455960assigned 07/08/2006
33bProvider typeSpecialist
28Total paid$1.01M
24GClaims102,926
24DCodes billed70
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Specialist providers in California
Rank by total paid#186 of 1,230
Median peer was paid$51K
This provider vs. median20×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,847 | $109K | |
| 2019 | 23,880 | $167K | |
| 2020 | 18,371 | $240K | |
| 2021 | 11,633 | $163K | |
| 2022 | 4,079 | $112K | |
| 2023 | 11,236 | $122K | |
| 2024incomplete | 16,880 | $102K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 19% | 6,902 | 4,318 | $194K |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | 12% | 861 | 857 | $124K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 12% | 4,003 | 1,065 | $121K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | 11% | 4,378 | 3,304 | $109K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.1% | 5,462 | 2,925 | $72K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 7.0% | 4,453 | 2,066 | $71K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 6.9% | 5,905 | 1,943 | $70K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.6% | 2,562 | 663 | $36K |
| 96361 | Intravenous infusion, hydration; each additional hour | 3.4% | 4,935 | 1,511 | $34K |
| 99335 | 3.3% | 1,462 | 1,437 | $33K | |
| J3490 | Unclassified drugs | 3.1% | 4,279 | 1,217 | $32K |
| 99223 | Prolong inpt eval add15 m | 1.8% | 261 | 252 | $18K |
58 more codes
| 99349 | 1.5% | 895 | $15K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.5% | 11,559 | $15K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 1.3% | 98 | $13K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.2% | 2,310 | $12K |
| 80053 | Comprehensive metabolic panel | <1% | 8,511 | $9K |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 1,190 | $8K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,740 | $3K |
| 99306 | Prolong nursin fac eval 15m | <1% | 70 | $3K |
| 85046 | <1% | 2,058 | $3K | |
| 82728 | <1% | 1,724 | $2K | |
| 83615 | <1% | 2,215 | $2K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 3,121 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,581 | $2K |
| 83735 | <1% | 4,022 | $2K | |
| 85651 | <1% | 1,081 | $2K | |
| 83550 | <1% | 1,627 | $1K | |
| 83540 | <1% | 1,677 | $1K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 176 | $942.49 |
| 96367 | <1% | 230 | $886.37 | |
| 82378 | <1% | 375 | $676.42 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 921 | $588.11 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,220 | $491.41 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 195 | $393.44 |
| 90694 | <1% | 14 | $377.33 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,032 | $368.41 |
| 86141 | <1% | 949 | $332.04 | |
| 80076 | <1% | 281 | $305.86 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 121 | $255.24 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 162 | $186.60 |
| 86300 | <1% | 43 | $156.58 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 243 | $143.77 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 383 | $134.17 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 199 | $128.12 |
| 85379 | <1% | 74 | $64.83 | |
| G0008 | Administration of influenza virus vaccine | <1% | 111 | $49.50 |
| 90674 | <1% | 66 | $46.18 | |
| 84436 | <1% | 168 | $43.66 | |
| 82746 | <1% | 77 | $42.63 | |
| 84479 | <1% | 169 | $41.91 | |
| 82397 | <1% | 416 | $38.82 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 103 | $36.13 |
| 80061 | Lipid panel | <1% | 180 | $33.35 |
| 90688 | <1% | 36 | $22.30 | |
| 83721 | <1% | 198 | $16.44 | |
| 85384 | <1% | 77 | $12.36 | |
| 84481 | <1% | 60 | $11.81 | |
| 85610 | <1% | 78 | $9.11 | |
| 85730 | <1% | 33 | $8.65 | |
| 84550 | <1% | 135 | $8.36 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 19 | $5.13 |
| 85670 | 0% | 75 | $0.00 | |
| 90653 | 0% | 17 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 177 | $0.00 |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 0% | 26 | $0.00 |
| 82607 | 0% | 69 | $0.00 | |
| 82533 | 0% | 44 | $0.00 | |
| 82784 | 0% | 19 | $0.00 | |
| 81001 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSPECTOR, MICHAEL (ADMINISTRATOR)